References
- Ringel SP, Murphy JR, Alderson MK et al. The natural history of amyotrophic lateral sclerosis. Neurology 1993; 43: 1316–1322.
- Smith SA, Miller RG, Murphy JR, Ringel SP. Treatment of ALS with high dose pulse cyclophosphamide. J Neurol Sci 1994; 124 (suppl) 84–87.
- Miller RG, Smith SA, Murphy JR et al. A clinical trial of verapamil in amyotrophic lateral sclerosis. Muscle & Nerve 1996; 19: 511–515.
- Miller RG, Sheppard R, Dao H et al. Controlled trial of nimodipine in amyotrophic lateral sclerosis. Neuromusc Disord 1996; 6: 101–104.
- Miller RG, Bryan WW, Dietz MA et al. Toxicity and tolerability of recombinant human ciliary neurotrophic factor (rhCNTF) in patients with amyotrophic lateral sclerosis (ALS). Neurology 1996; 47: 1329–1331.
- Miller RG, Petajan JH, Bryan WW et al., and the rhCNTF ALS Study Group. A placebo controlled trial of recombinant human ciliary neurotrophic (rhCNTF) factor in amyotrophic lateral sclerosis. Ann Neurol 1996; 39:256–260.
- Hoagland RJ, Armon C, Bryan WW et al., and the syntax synergen neuroscience Joint Venture rhCNTF ALS. Reliability of maximal voluntary isometric contraction testing in a multicenter study of patients with amyotrophic lateral sclerosis. Muscle & Nerve 1997; 20: 691–695.
- Miller RG, Moore D, Young LA et al., and the WALS Study Group. Placebo controlled trial of gabapentin in patients with amyotrophic lateral sclerosis. Neurology 1996; 47: 1383–1388.
- Miller RG, Moore DH, Gelinas DF et al., and the WALS Study Group. Phase III randomized trial of gabapentin in patients with amyotrophic lateral sclerosis. Neurology 2001; 56: 843–848.
- Moore DH, Miller RG., and the Western ALS Study Group. Improving efficiency of ALS Clinical Trials. (12th International Symposium on ALS/MND) ALS Other MND 2001; 2: 20.
- Moore DH, Miller RG. Improving efficiency of ALS clinical trials using lead-in designs. ALS and other Motor Neur Disords. In Press, 2003.
- Florence HM, Moore DH, Mendoza M et al. Validation of Tele- phonic Administration of the ALSFRSR. (American Academy of Neurology 56th Annual Meeting) Neurology 2004; 7(suppl 5): A134.